The findings, published in the journal AIDS, highlight the complexity of the outbreak and may have implications on future HIV vaccine development in the region.
New findings from an RV144 follow-on study published today in Science Translational Medicine provide key insights into the role that host-genetics played in protecting against HIV-1 infection during the landmark “Thai Study.”
Dr. Ananworanich will oversee adult HIV therapeutic trials as part of the newly-funded MHRP Clinical Trials Unit under the AIDS Clinical Trials Group (ACTG).